What is Premier Allergy & Asthma?
Headquartered in Columbus, Ohio, Premier Allergy & Asthma operates as a premier provider of specialized medical care, focusing on the diagnosis and treatment of complex allergic conditions and respiratory health. With a network of 13 clinics, the practice distinguishes itself through a patient-centric model that integrates board-certified expertise with innovative immunotherapy protocols. The company serves a broad demographic, ranging from pediatric patients to adults, addressing critical health needs such as food sensitivities, seasonal allergies, and chronic asthma management. By maintaining a high standard of clinical excellence, the firm has established itself as a dominant player in the regional healthcare market, effectively bridging the gap between primary care and specialized immunological intervention.
How much funding has Premier Allergy & Asthma raised?
Premier Allergy & Asthma has raised a total of $926K across 2 funding rounds:
Debt
$350K
Debt
$576K
Debt (2020): $350K with participation from PPP
Debt (2021): $576K led by PPP
Key Investors in Premier Allergy & Asthma
PPP
Public-Private Partnership
What's next for Premier Allergy & Asthma?
With the recent infusion of capital, Premier Allergy & Asthma is well-positioned to scale its clinical operations and enhance its technological capabilities in patient management. The strategic focus will likely shift toward expanding its geographic reach within Ohio and potentially neighboring states, while simultaneously investing in advanced diagnostic tools to improve patient outcomes. As the organization matures, the integration of data-driven treatment plans and the potential for further service diversification will be pivotal in maintaining its competitive advantage. This enterprise-level financing provides the necessary liquidity to navigate the evolving landscape of private medical practice, ensuring long-term sustainability and continued excellence in specialized patient care.
See full Premier Allergy & Asthma company page
